Suggestions
Jeffrey Reid
Vice President, RGC Chief Data Officer
Jeffrey Reid is a prominent figure in the field of genomics and personalized medicine, currently serving as the Vice President and RGC Chief Data Officer at Regeneron.1 Based in Tarrytown, New York, Reid has been in this role since January 2021.1
Professional Background
Reid's work focuses on driving the personalized medicine revolution through large-scale genomics in the cloud.1 He is deeply involved in applying emerging AI and machine learning tools to find equitable solutions for scientific discovery.3
Expertise and Interests
Reid's areas of expertise include:
- Genomics
- Artificial Intelligence in healthcare
- Data transformation in genetics
- Sequencing informatics
He frequently shares insights and engages in discussions about the role of AI in the future of healthcare and scientific discovery.2 Reid is also passionate about equity in leadership, as evidenced by his interest in the Berkeley Haas Center for Equity, Gender & Leadership's #EquityFluentLeadership Academy.4
Professional Activities
Reid is active in the biotechnology community, participating in events such as the Fierce Biotech Summit where he shares his expertise with other industry leaders.6 He has been involved in sharing the Regeneron Genetics Center's journey in data and AI transformation.5
Jeffrey Reid's LinkedIn profile (username: j-g-reid) serves as a platform for him to share professional updates, insights, and engage with others in the field of genomics and AI in healthcare.
Highlights
Just when we thought we could hold on to those last fading rays of summer sun ☀️, reality knocks on our door with the familiar sounds of alarm clocks, school bells, and the hum of office chatter. 🍂📚✏️ But fear not! While we might be trading beach days for board meetings, we've got something exciting to ease the transition...
Introducing The Nucleus by Regeneron! A podcast exploring the science that fascinates and inspires us.🎙️🚀
In the first episode, I had the pleasure of hosting a conversation with Daphne Koller, Founder and CEO of insitro. We dive into how cutting-edge AI and machine learning tools are driving equitable scientific discovery and transforming healthcare. From accelerating drug discovery to personalizing medical treatments, this is a discussion you won't want to miss.
Whether you're stuck in traffic, sipping your morning coffee, or sneaking in a listen between classes, the Nucleus is here to keep you inspired, informed, and entertained. Join us as a rotating cast of hosts dive into fascinating topics, interview industry leaders, and explore the stories that matter to you.
Tune in now and let’s make the return to routine a little more fun and a lot more insightful! #TheNucleus #Regeneron #RGC #AI #MachineLearning #Science #DEI
Thank you so much Rachel Bray and the whole CERN Alumni team for organizing a truly remarkable 'Third Collisions' alumni event at CERN. It's been more than 20 years since I've been here and it was an absolute joy to see how CERN has grown and evolved -- especially the visit to A Large Ion Collider Experiment (ALICE). The last thing I did as a physicist was ALICE data simulations, so seeing it with my own eyes was like a dream come true.
I also enjoyed enormously exploring the intersection of physics and healthcare in the panel discussion with Dr. Zoë André-Lawson, MBA & Benjamin Frisch. Hopefully we helped inspire more physicists to apply their talents to the research challenges of healthcare. There are so many opportunities with emerging technologies to have an impact on health in drug discovery and manufacturing, I have no doubt that science and technology from CERN will help build a healthier future -- especially with Benjamin, Ash Ravikumar, and the rest of the knowledge transfer group working to maximize the global positive impact of CERN on society.
Finally, thanks to all the other attendees, I'm already looking forward to the Fourth Collision in 2027!
